Busca avançada
Ano de início
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Composite acute phase glycoproteins with coronary artery calcification depends on metabolic syndrome presence - The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)

Texto completo
Harada, Paulo H. [1] ; Bensenor, Isabela M. [1, 2] ; Bittencourt, Marcio S. [1] ; Nasir, Khurram [3, 4] ; Blaha, Michael J. [3] ; Jones, Steven R. [3] ; Toth, Peter R. [3, 5] ; Lotufo, Paulo A. [1, 2]
Número total de Autores: 8
Afiliação do(s) autor(es):
[1] Univ Sao Paulo, Univ Hosp, Ctr Clin & Epidemiol Res, Ave Lineu Prestes, 2565, BR-05508000 Sao Paulo - Brazil
[2] Univ Sao Paulo, Dept Med, Sch Med, Sao Paulo - Brazil
[3] Johns Hopkins Univ, Ciccarone Ctr Prevent Heart Dis, Baltimore, MD - USA
[4] Yale Univ, YNHH, Populat Hlth & Hlth Syst Res, Ctr Outcomes Res & Evaluat, New Haven, CT - USA
[5] Univ Illinois, Coll Med Peoria, Illinois CGH Med Ctr, Sterling, IL - USA
Número total de Afiliações: 5
Tipo de documento: Artigo Científico
Fonte: JOURNAL OF CARDIOLOGY; v. 73, n. 5, p. 408-415, MAY 2019.
Citações Web of Science: 1

Background: Inflammation has been weakly associated with coronary artery calcium (CAC) in the overall population. However, it is currently unknown whether this varies according to the cardio-metabolic profile. We evaluated the association between GlycA, a unique composite biomarker of pro-inflammatory acute phase glycoproteins, high sensitivity C-reactive protein (hsCRP), uric acid, and their composite values (composite inflammation) in the overall population and strata according to cardiovascular risk. Methods: This is a cross-sectional study of 3753 Sao Paulo site participants of the ELSA-Brasil cohort that were free of cardiovascular/chronic inflammatory disease and not taking statins or allopurinol. We measured GlycA by nuclear magnetic resonance spectroscopy. For each biomarker quartile (Qs), we ran adjusted logistic and linear regression for CAC > 0 and CAC score. Results: In the overall analysis, the 4th vs. 1st GlycA Q odds ratio (OR) for CAC > 0 was 1.53 (95% CI: 1.18, 1.98, p trend < 0.001) adjusted for demographics and lifestyle, but null after adding metabolic syndrome (MS) components, OR 1.14 (95% CI: 0.86,1.51, p trend = 0.140). Likewise, for continuous CAC values there was no difference across GlycA Qs in the fully adjusted analysis. Similarly, hsCRP, uric acid, and composite inflammation were not associated with CAC > 0 or CAC score. In stratified analysis, GlycA was associated with CAC > 0 in No-MS individuals, standardized (SD) OR 1.23 (95% CI: 1.08, 1.40); but not in MS individuals, SD OR 1.01 (95% CI: 0.89,1.15)(p interaction 0.037). We found similar interaction in stratified analysis for continuous CAC on composite inflammation. Conclusions: GlycA and composite inflammation are associated with CAC among low cardiovascular risk individuals (No-MS), but not otherwise. GlycA and composite biomarkers may better represent sources of inflammation apart from visceral obesity and traditional cardiovascular risk factors, which may have relevant effect on CAC accumulation in low cardiovascular risk individuals. (C) 2018 Published by Elsevier Ltd on behalf of Japanese College of Cardiology. (AU)

Processo FAPESP: 11/12256-4 - Escore de cálcio e anatomia coronariana na identificação de risco de doença coronariana no Estudo Longitudinal de Saúde do Adulto (ELSA-Brasil)
Beneficiário:Paulo Andrade Lotufo
Linha de fomento: Auxílio à Pesquisa - Regular